Puts Purchased on Endo Pharmaceuticals Holdings Inc. (ENDP)

Shares of Endo Pharmaceuticals Holdings Inc. ENDP are lower on the session by 2.54%, currently trading at $34.31. The stock has been moving largely sideways over the past six months and is currently trading above the 200-day moving average.

Options traders are buying puts on the name today. A short while ago the April 2011 $35.00 put was purchased 1,500 times, on the offer, on open interest of 399 contracts.

Overall put volume is now running at 9.15x the daily average with 99% of all puts traded being purchases on the offer.

Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company in pain management. The company is engaged in the research, development, manufacturing, marketing and sales of branded and generic pharmaceutical products used primarily to treat and manage pain, overactive bladder, prostate and bladder cancer and central precocious puberty.